Previous Close | 10.89 |
Open | 10.89 |
Bid | 0.00 x 800 |
Ask | 0.00 x 1300 |
Day's Range | 10.43 - 11.07 |
52 Week Range | 8.75 - 95.34 |
Volume | |
Avg. Volume | 6,980,414 |
Market Cap | 887.442M |
Beta (5Y Monthly) | 1.72 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -17.51 |
Earnings Date | Feb 27, 2023 - Mar 03, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 55.33 |
Novavax (NVAX) closed the most recent trading day at $11.09, moving -1.25% from the previous trading session.
The two companies, known for their vaccines, could see their businesses benefit from a yearly COVID-19 shot.
Companies whose businesses were buoyed or boosted by Covid product demand are facing a cliff in 2023, and will have to pivot to more traditional strategies.